| HER2-Positive Breast Carcinoma predicts response to …PREDICTS_RESPONSE_TO65 of 65show fewer |
|---|
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Trastuzumab 2 source records aggregated | sensitivity | A | HER2-Positive Breast Carcinoma | 2 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Neratinib | sensitivity | A | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Trastuzumab 10 source records aggregated | sensitivity | B | HER2-Positive Breast Carcinoma | 10 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Lapatinib 5 source records aggregated | sensitivity | B | HER2-Positive Breast Carcinoma | 5 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Afatinib 4 source records aggregated | sensitivity | B | HER2-Positive Breast Carcinoma | 4 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Trastuzumab Emtansine 4 source records aggregated | sensitivity | B | HER2-Positive Breast Carcinoma | 4 | Curated | civic | graph → |
| in context · predicts response to | PTEN Lossdeletion_cna → predicts response to Trastuzumab 2 source records aggregated | resistance | B | HER2-Positive Breast Carcinoma | 2 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA Mutationother → predicts response to Trastuzumab 2 source records aggregated | resistance | B | HER2-Positive Breast Carcinoma | 2 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Docetaxel 2 source records aggregated | sensitivity | B | HER2-Positive Breast Carcinoma | 2 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Pertuzumab 2 source records aggregated | sensitivity | B | HER2-Positive Breast Carcinoma | 2 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Capecitabine 2 source records aggregated | sensitivity | B | HER2-Positive Breast Carcinoma | 2 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA Mutationother → predicts response to Lapatinib | resistance | B | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA Mutationother → predicts response to Capecitabine | resistance | B | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Neratinib | sensitivity | B | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Overexpressionexpression → predicts response to Trastuzumab Emtansine | sensitivity | B | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | BIRC5 Overexpressionexpression → predicts response to Trastuzumab | resistance | B | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Lossdeletion_cna → predicts response to Everolimus | sensitivity | B | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA Mutationother → predicts response to Everolimus | sensitivity | B | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Expressionexpression → predicts response to Fulvestrant | resistance | C | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Expressionexpression → predicts response to Everolimus | resistance | C | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA H1047RSNV → predicts response to Fulvestrant | sensitivity | C | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA H1047RSNV → predicts response to Everolimus | sensitivity | C | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA E545KSNV → predicts response to Trastuzumab 4 source records aggregated | resistance | D | HER2-Positive Breast Carcinoma | 4 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA H1047RSNV → predicts response to Trastuzumab 3 source records aggregated | resistance | D | HER2-Positive Breast Carcinoma | 3 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA Overexpressionexpression → predicts response to Lapatinib 2 source records aggregated | sensitivity | D | HER2-Positive Breast Carcinoma | 2 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Trastuzumab 2 source records aggregated | sensitivity | D | HER2-Positive Breast Carcinoma | 2 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA E545KSNV → predicts response to Lapatinib 2 source records aggregated | resistance | D | HER2-Positive Breast Carcinoma | 2 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA H1047RSNV → predicts response to Lapatinib 2 source records aggregated | resistance | D | HER2-Positive Breast Carcinoma | 2 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA H1047RSNV → predicts response to Capivasertib 2 source records aggregated | sensitivity | D | HER2-Positive Breast Carcinoma | 2 | Curated | civic | graph → |
| in context · predicts response to | PTEN Lossdeletion_cna → predicts response to PI3Ka/Di | resistance | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA K111NSNV → predicts response to PI3Ka/Di | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA E545KSNV → predicts response to PI3Ka/Di | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA E542KSNV → predicts response to PI3Ka/Di | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Lossdeletion_cna → predicts response to PI-103 | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA K111NSNV → predicts response to PI-103 | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA E542KSNV → predicts response to PI-103 | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA C420RSNV → predicts response to Trastuzumab | resistance | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Underexpressionexpression → predicts response to Dactolisib | resistance | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA K111NSNV → predicts response to Dactolisib | resistance | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Underexpressionexpression → predicts response to Trastuzumab | resistance | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA K111NSNV → predicts response to Trastuzumab | resistance | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA Amplificationamplification → predicts response to Dactolisib | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA Amplificationamplification → predicts response to Lapatinib | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA Overexpressionexpression → predicts response to Trastuzumab | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA Overexpressionexpression → predicts response to Dactolisib | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA Overexpressionexpression → predicts response to Trastuzumab | resistance | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA E542KSNV → predicts response to Pictilisib | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Palbociclib | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA Mutationother → predicts response to Capivasertib | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Lossdeletion_cna → predicts response to Trastuzumab | resistance | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to A66 | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB4 EXPRESSIONexpression → predicts response to Trastuzumab | resistance | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA C420RSNV → predicts response to Pictilisib | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Lossdeletion_cna → predicts response to Pictilisib | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA H1047RSNV → predicts response to Lapatinib | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA H1047RSNV → predicts response to Trastuzumab | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Lossdeletion_cna → predicts response to PI3K/BET Inhibitor LY294002 | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Lossdeletion_cna → predicts response to Trastuzumab | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Pictilisib | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PTEN Underexpressionexpression → predicts response to Lapatinib | resistance | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA K111NSNV → predicts response to Lapatinib | resistance | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA H1047RSNV → predicts response to Pictilisib | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA K111NSNV → predicts response to Pictilisib | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | PIK3CA E545KSNV → predicts response to Pictilisib | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Pilaralisib | sensitivity | D | HER2-Positive Breast Carcinoma | 1 | Curated | civic | graph → |